Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors
- 31 March 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (4) , 675-679
- https://doi.org/10.1016/0277-5379(88)90298-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Have new aggressive chemotherapy regimens improved results in advanced germ cell tumors?European Journal of Cancer and Clinical Oncology, 1986
- Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumorsThe American Journal of Medicine, 1985
- High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.Journal of Clinical Oncology, 1984
- Etoposide salvage therapy for refractory germ cell tumors: an updateCancer Treatment Reviews, 1982
- VP16-213 as a single agent in advanced testicular tumorsPublished by Elsevier ,1980
- High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumorsCancer, 1980
- Infection prevention in granulocytopenic patients by selective decontamination of the digestive tractPublished by Elsevier ,1980
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISPublished by Elsevier ,1979
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977